Clinical safety of intrathecal administration of mesenchymal stromal cell-derived neural progenitors in multiple sclerosis.

Read so far
less than 1 minute
Staff: 
Saud A. Sadiq, MD, FAAN
Violaine K. Harris, PhD
Tamara Vyshkina, PhD